VivoSim Labs, Inc. (VIVS)
0.1577
+0.01
(+8.24%)
USD |
NASDAQ |
Oct 29, 16:00
0.153
0.00 (0.00%)
After-Hours: 20:00
VivoSim Labs Gross Profit Margin (Quarterly) : -122.2% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -122.2% |
| March 31, 2026 | -7.50% |
| December 31, 2025 | -100.0% |
| September 30, 2025 | -110.7% |
| June 30, 2025 | -64.86% |
| March 31, 2025 | -19.61% |
| December 31, 2024 | -187.5% |
| September 30, 2024 | -133.3% |
| June 30, 2024 | -84.62% |
| March 31, 2024 | -141.4% |
| December 31, 2023 | -1.34K% |
| September 30, 2023 | |
| June 30, 2023 | 10.67% |
| March 31, 2023 | 63.58% |
| December 31, 2022 | 0.76% |
| September 30, 2022 | 28.57% |
| June 30, 2022 | |
| March 31, 2022 | 96.93% |
| December 31, 2021 | |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | |
| September 30, 2020 | |
| June 30, 2020 |
| Date | Value |
|---|---|
| March 31, 2020 | |
| December 31, 2019 | -159.4% |
| September 30, 2019 | 64.39% |
| June 30, 2019 | 61.68% |
| March 31, 2019 | 61.76% |
| December 31, 2018 | 49.94% |
| September 30, 2018 | 56.84% |
| June 30, 2018 | 40.78% |
| March 31, 2018 | 46.88% |
| December 31, 2017 | 55.94% |
| September 30, 2017 | 69.41% |
| June 30, 2017 | 37.58% |
| March 31, 2017 | 57.45% |
| December 31, 2016 | 53.61% |
| September 30, 2016 | 71.44% |
| June 30, 2016 | 52.97% |
| March 31, 2016 | 0.00% |
| December 31, 2015 | 0.00% |
| September 30, 2015 | 37.21% |
| June 30, 2015 | 0.00% |
| March 31, 2015 | 0.00% |
| December 31, 2014 | 18.71% |
| September 30, 2014 | -124.0% |
| June 30, 2014 | 0.00% |
| March 31, 2014 | 13.91% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Agenus, Inc. | 98.50% |
| Amgen, Inc. | 72.08% |
| Anika Therapeutics, Inc. | 65.15% |
| BioCryst Pharmaceuticals, Inc. | 98.01% |
| Imunon, Inc. | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -350.5% |
| Return on Assets | -154.3% |
| Return on Invested Capital | -291.5% |
| Profit Margin (Quarterly) | -7.43K% |
| Operating Margin (Quarterly) | -15.33K% |
| Return on Net Operating Assets | -1.23K% |